CIBC Private Wealth Group’s Phibro Animal Health PAHC Stock Holding History

CIBC Private Wealth Group’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$187	Buy	+5	New	+$203	﹤0.01%	3229

Other funds holding PAHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CIBC Private Wealth Group's PAHC Position: Q4 2025 in Review

CIBC Private Wealth Group opened a new position in Phibro Animal Health (PAHC) in Q4 2025: 5 shares worth $187. The stake represents ﹤0.01% of the portfolio and ranks #3229 among its holdings.

227 funds tracked by Wall St. Rank hold PAHC as of Q4 2025.

CIBC Private Wealth Group held 5 shares of Phibro Animal Health worth $187 as of Q4 2025.
Phibro Animal Health was a new CIBC Private Wealth Group position in Q4 2025.
Phibro Animal Health made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #3229 holding.
227 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.